Home LiteratureArticle Details
PMID: 8691132 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.

The Journal of experimental medicine ·Vol. 184 ·No. 1 ·1996-07-01 ·Pages 183-9

Larsen SL, Pedersen LO, Buus S, Stryhn A

Abstract

Endocytosed protein antigens are believed to be fragmented in what appears to be a balance between proteolysis and MHC-mediated epitope protection, and the resulting peptide-MHC complexes are transported to the surface of the antigen-presenting cells (APC) and presented to T cells. The events that lead to antigenic peptide generation and the compartments where antigen processing takes place remains somewhat enigmatic. The importance of intracellular antigen processing has been well established; however, it is unclear whether additional processing occurs at the APC surface. To follow antigen processing, we have identified a pair of T cell hybridomas that recognize a long vs. a short version of the same epitope. We have used prefixed APC and various protease inhibitors to demonstrate that the APC surface has a considerable potential for antigen processing. Specific antibodies further identified the exopeptidase Aminopeptidase N (APN, CD13) as one of the enzymes involved in the observed cell-surface antigen processing. The NH2-terminal end of the longer peptide could, even while bound to major histocompatibility complex (MHC) class II molecules, be digested by APN with dramatic consequences for T cell antigen recognition. This could be demonstrated both in cell-free systems using purified reagents and in cellular systems. Thus, MHC class II and APN may act in concert to generate the final T cell epitopes.

MeSH Terms
Amino Acid Sequence Animals Antigen-Presenting Cells/enzymology CD13 Antigens/metabolism Histocompatibility Antigens Class II/metabolism Hybridomas Lymphocyte Activation Mice Molecular Sequence Data Muramidase/chemistry,immunology Peptides/immunology,metabolism T-Lymphocytes/immunology Tumor Cells, Cultured
Chemicals
Histocompatibility Antigens Class II Peptides Muramidase CD13 Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Larsen S L
Department of Experimental Immunology, University of Copenhagen, Denmark.
Pedersen L O
Buus S
Stryhn A
References (36)
36 references, click to expand
  1. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.
    J Immunol. 1981 Nov;127(5):1869-75 PMID: 6795263
  2. Separation and characterization of two component tumor lines within the AKR lymphoma, AKTB-1, by fluorescence-activated cell sorting and flow microfluorometry analysis. II. Differential histopathology of sIg+ and sIg- sublines.
    J Immunol. 1982 Apr;128(4):1832-8 PMID: 7061851
  3. Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice.
    Immunogenetics. 1982;16(4):367-71 PMID: 6983495
  4. Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.
    J Immunol. 1983 Sep;131(3):1160-6 PMID: 6604091
  5. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.
    J Exp Med. 1983 Aug 1;158(2):303-16 PMID: 6193218
  6. Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas.
    Proc Natl Acad Sci U S A. 1984 Apr;81(8):2489-93 PMID: 6201858
  7. Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule.
    J Immunol. 1985 Jul;135(1):368-73 PMID: 2582039
  8. Binding of immunogenic peptides to Ia histocompatibility molecules.
    Nature. 1985 Sep 26-Oct 2;317(6035):359-61 PMID: 3876513
  9. Oligopeptide antigens of the angiotensin lineage compete for presentation by paraformaldehyde-treated accessory cells to T cells.
    J Immunol. 1986 Jan;136(2):459-65 PMID: 3484493
  10. Isolation and characterization of antigen-Ia complexes involved in T cell recognition.
    Cell. 1986 Dec 26;47(6):1071-7 PMID: 3490919
  11. Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages.
    Scand J Immunol. 1986 Dec;24(6):625-36 PMID: 2432653
  12. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.
    Science. 1987 Mar 13;235(4794):1353-8 PMID: 2435001
  13. T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing.
    J Immunol. 1988 Feb 15;140(4):1063-8 PMID: 2449493
  14. Binding to Ia protects an immunogenic peptide from proteolytic degradation.
    J Immunol. 1989 Feb 15;142(4):1063-8 PMID: 2783704
  15. Capacity of intact proteins to bind to MHC class II molecules.
    J Immunol. 1989 Aug 15;143(4):1265-7 PMID: 2787361
  16. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M.
    Biochem Pharmacol. 1990 Oct 15;40(8):1725-32 PMID: 1978675
  17. Sequence analysis of peptides bound to MHC class II molecules.
    Nature. 1991 Oct 17;353(6345):622-7 PMID: 1656276
  18. pH dependence of the interaction between immunogenic peptides and MHC class II molecules. Evidence for an acidic intracellular compartment being the organelle of interaction.
    J Immunol. 1992 Mar 1;148(5):1438-44 PMID: 1538129
  19. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules.
    J Exp Med. 1992 May 1;175(5):1221-6 PMID: 1314884
  20. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.
    Science. 1992 Jun 26;256(5065):1817-20 PMID: 1319610
  21. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7380-3 PMID: 1323833
  22. MHC molecules protect T cell epitopes against proteolytic destruction.
    J Immunol. 1992 Sep 15;149(6):1987-93 PMID: 1381392
  23. Surface contact requirements for activation of cytotoxic T lymphocytes.
    J Immunol. 1992 Oct 1;149(7):2402-5 PMID: 1527386
  24. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes.
    Cell. 1992 Dec 11;71(6):963-72 PMID: 1333889
  25. The biochemistry and cell biology of antigen processing and presentation.
    Annu Rev Immunol. 1993;11:403-50 PMID: 8476568
  26. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  27. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
    Eur J Immunol. 1993 Jul;23(7):1602-7 PMID: 7686856
  28. A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules.
    Eur J Immunol. 1993 Sep;23(9):2358-64 PMID: 8103749
  29. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    J Immunol. 1993 Nov 1;151(9):4732-42 PMID: 8409432
  30. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Eur J Immunol. 1994 Feb;24(2):385-92 PMID: 8299688
  31. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
    Immunogenetics. 1994;39(4):230-42 PMID: 8119729
  32. Preformed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomas.
    Eur J Immunol. 1994 Jun;24(6):1404-9 PMID: 8206101
  33. Pig kidney particulate aminopeptidase. A zinc metalloenzyme.
    Biochim Biophys Acta. 1973 Sep 15;321(1):274-81 PMID: 4201532
  34. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.
    J Exp Med. 1981 May 1;153(5):1198-214 PMID: 6166712
  35. MHCDB--database of the human MHC.
    Immunogenetics. 1994;40(2):109-15 PMID: 8026859
  36. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method.
    Biochim Biophys Acta. 1995 Apr 13;1243(3):453-60 PMID: 7537104
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1996-07-01
Pages
183-9
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192675
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com